
Chimeric Antigen Receptor T-cell therapy in 2020: Current Indications
Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges
Mohamed Kharfan-Dabaja, MD

Immunotherapy for Gynecology-Oncology Malignancies: Is There Still Time for Progress?
Oladap O. Yeku, MD, PhD, FACP